Announcements Trials
Browse Landscape

Status

Completed 19Recruiting 5Terminated 4Unknown 3Withdrawn 2No longer available 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 2

Interventions

tazemetostat 2Trabectedin 2TH 302 1DOXO-EMCH 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Sarcoma × Trabectedin × Clear all
NCT00210665 2017-10-10

A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

Janssen Research & Development, LLC

No longer available
Sarcoma

Sarcoma

NCT01427582 2011-09-01

YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access

University of Texas Southwestern Medical Center

No longer available
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡